1. Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target;Stevenson;Cancer Surv,1980
2. Two distinct mechanisms of anti-tumour activity mediated by the combination of interleukin 2 and monoclonal antibodies;Vuist;Cancer Res,1990
3. Monoclonal anti- human tumour antibodies of six isotypes in cytotoxic reactions with human and murine effector cells;Herlyn;Cell Immunol,1985
4. Influence of antibody isotype on passive serotherapy of lymphoma;Denkers;J Immunol,1985
5. Lymphokine-activated killer cells targeted by monoclonal antibodies to the disialogangliosides GD2 and GD3 specifically lyse human tumour cells of neuroectodermal origin;Honsik,1986